Caregiving
Practical ground for the people doing the work.
A University of Michigan pilot of the Roadmap app found dementia caregivers logged a positive activity on 87 percent of days, and reported less stress on the days they did. It was a feasibility study, with no control group, and the authors say the real trial has not happened yet.
In a single-arm pilot of 48 Chinese American dementia caregivers, positive views of caregiving rose 96 percent after a seven-week Chinese-language program delivered entirely through WeChat. Burden and depression stayed where they were, and there was no comparison group.
Fifteen family caregivers in British Columbia told researchers what changed when an adult day program kept its doors open past dinner: the same faces at midnight, and, for some of them, seven or eight hours of sleep.
In a 274-person trial spanning 43 countries, dementia caregivers who used a self-guided, chatbot-driven psychoeducation program called PDC30 reported less depression and less burden after one month than those left on a waiting list. No clinician ever entered the exchange.
CareMirror, a prototype posted as a preprint in September 2026, puts caregiver wellbeing into the dementia care record. Fourteen caregivers walked through it and said yes, with conditions, and the conditions did most of the talking.
The Massachusetts House voted unanimously on July 29, 2026 to require acute care hospitals to notify a designated family member or caregiver soon after a dementia patient is admitted and again before discharge. The bill, which also expands diagnosis notification and creates a new MassHealth care coordination benefit, now heads to the Senate.
A survey of 1,254 nurses and aides across 77 Hungarian residential institutions found that about a fifth of the variation in burnout severity sat between facilities, not between individuals. What the study cannot say is which features of a facility made the difference.
A humanoid named Pepper has been taught to deliver Alzheimer's caregiver coaching from a verified manual. The first published test asked whether it gets the answers right, not whether it helps anyone yet.
A bill introduced in the Senate would credit hours spent bathing, medicating and transporting a relative with an age-related condition toward eligibility for bigger retirement contributions, but it is still sitting in committee with no vote scheduled.
A new Swedish interview study asked 21 family members how they came to be called, or to call themselves, a caregiver. The answers were less a moment than an accident of circumstance.
A quality improvement project at Oregon Health and Science University screened 405 family caregivers in a movement disorders clinic for burden and sent the highest scorers to a social worker; only a small fraction returned to be measured again.
The Administration for Community Living has posted a new round of federal grants for state respite care systems, including a companion track set aside specifically for dementia-specific respite programs, agency notices show.
The National Institute on Aging has published the finalized report from its fourth triennial Dementia Care and Caregiving Research Summit, naming five research areas and a list of gaps it wants filled next, including a fresh estimate that dementia now costs the country up to $800 billion a year.
A 280-dyad trial in Norway measured, in hours per month, what family caregivers actually do, and found that a six-month coordinator program did not significantly ease the load.
A small pilot in Clinical Gerontologist tested a structured remote program built for family caregivers who live at least two hours from the person with dementia. Forty took part. It is early evidence, not proof.
A synthesis of eight studies covering more than 3,000 people finds some respite models are linked to less caregiver stress and burden, but says the evidence on costs and quality is too weak to draw firm conclusions.
In an 18-month trial of 2,176 families, two structured dementia care programs, one run through health systems and one through community organizations, did not ease caregiver strain or improve outcomes for people living with dementia compared with usual care. Caregivers did report greater satisfaction with the care itself.
A new AARP valuation puts the replacement cost of unpaid family caregiving at just over $1 trillion for 2024, a figure the report says exceeds national Medicaid spending, though it does not separate out how much of that work involves caring for someone with dementia.
A new federal comparative-effectiveness award will test an in-person caregiver program against a self-guided digital version directly against each other, rather than against usual care. No results exist yet; the trial is only now getting underway.
A 61-caregiver feasibility study published in Frontiers in Aging Neuroscience tested a structured, three-month home-care protocol against usual nursing guidance, reporting it could be delivered and completed, with early gains in caregiver knowledge and mental health measures that the authors say now need to be tested in a larger trial.
JMIR Research Protocols has published the design for a pilot randomized controlled trial of CarePair, a mobile self-assessment and referral platform meant to connect family caregivers of people with Alzheimer's and related dementias to home and community services faster. No results exist yet: this is the trial's blueprint, not its findings.
A nationwide study of Spanish discharge data counts 2,477 admissions between 2016 and 2022, with deaths tracking comorbidity rather than the encephalopathy itself
Pooled data from published studies show a large gap in recognising faces and tone of voice, a large gap in mentalising, and much thinner evidence on empathy and self-awareness
Amsterdam UMC researchers interviewed 14 pairs, the person with the diagnosis and the family member caring for them, about impaired awareness in dementia, Huntington's disease and Korsakoff's syndrome. Both sides were in the room, and they described two different lives.
A qualitative study from the Centre of Excellence for Korsakoff and Alcohol-Related Cognitive Disorders asked three residents, two relatives and 14 professionals what the SABA programme gets wrong for Korsakoff's syndrome. The adapted version has not yet been tested.
In 808 brains from the National Alzheimer's Coordinating Center, Alzheimer's change plus vascular injury tracked with faster decline in only one of five cognitive domains, and by less than the two pathologies would predict added together. Alzheimer's plus Lewy body disease was worse in four domains, and fully additive.
A Karolinska team followed 32,282 people with Alzheimer's or mixed dementia through routine Swedish care for up to 11 years, tracking who was on a cholinesterase inhibitor, who was on memantine, and what happened to their test scores. The differences are real, modest, and not from a trial.
A cohort of 571,663 people in English general practice records found mixed dementia was the only group more likely than Alzheimer's to get an annual care plan, yet every non-Alzheimer's subtype carried higher rates of potentially inappropriate prescribing.
A small qualitative study from Beaumont and Limerick asked family carers of people with Huntington's disease what the job feels like. The genetic dread they described was real, but it pointed at their children, not at themselves.
A new European interview study asks people with Huntington's disease and their family caregivers what the household absorbs. The answers are unsurprising to families and inconvenient for care systems. The funder, F. Hoffmann-La Roche, set the study's scope.
Interviews with 13 psychologists working in Netherlands Huntington's services set out what psychological support consists of from the at-risk years to the nursing home, and where it runs into limits: cognitive change, lack of disease awareness, and referrals that go nowhere useful.
The agency's guidance for funeral and crematory practitioners, revised 21 January 2026, says classic Creutzfeldt-Jakob disease requires no special interment, entombment, inurnment or cremation, and a UK community policy reissued in March 2026 says isolation is not required at home.
A Spanish pedigree study reported that children of a parent carrying a PRNP mutation inherit it about two thirds of the time. UK and US prion researchers say the recruitment method inflated that number, and the authors have replied.
A PROSPERO-registered systematic review in BMC Palliative Care pooled 30 studies covering 4,434 people with rapidly progressive prion disease. It found the fullest ranking of what is hardest to live with still comes from a 2019 survey of 71 family carers, not from measurement.
A 35-author panel, including a lived-experience representative, has published practical recommendations for Creutzfeldt-Jakob disease in Age and Ageing, with a dedicated section on support for families and professionals.
CMS has proposed a 3.0% temporary cut to the base 30-day payment rate alongside a net 2.4% rise in total home health spending, and the recalibrated visit thresholds that shape care at home are open to public comment until 5 p.m. EDT on 31 August 2026.
CMS finalised its FY 2027 hospice rule on 30 July, making the election statement addendum mandatory from 1 October and publishing a service and spending variation score for each hospice. Dementia diagnoses accounted for the largest share of spending outside the benefit.
Auvelity's expanded label covers adults with agitation associated with dementia due to Alzheimer's disease. The boxed warning, the antidepressant interactions and the bar on as-needed dosing all remain.
LiBBY, a 120-person randomised trial run at US medical centres with visits in people's homes, met its two-week endpoint on the Cohen-Mansfield Agitation Inventory. The results were presented at a conference in July and have not yet been published in a peer-reviewed journal.
A Federal Register notice of 24 July asks the public to help set the goals of the plan through 2035, four weeks after the Government Accountability Office said the department could not show whether the current goals were being met.